ArticlePloS one2021

The limits of personalization in precision medicine: Polygenic risk scores and racial categorization in a precision breast cancer screening trial.

Jennifer Elyse James et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.